Neuro

InspireMD Announces Distribution Agreement For CGuard EPS In Portugal

TEL AVIV, ISRAEL–(Marketwired – September 21, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE American: NSPR) (NYSE MKT: NSPR.WS) (NYSE American: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Medicinália Cormédica MC Medical Lda, a […]

IMRIS’ Annual Sales Grow Nearly 50% After Bankruptcy Sale

MINNETONKA, Minn., Sept. 12, 2017 /PRNewswire/ — IMRIS, the global leader in intraoperative imaging, recently celebrated its two-year anniversary under new ownership with strong financial growth and strategic investments for continued future success. Through a reorganization and the backing of parent company Deerfield Management in August 2015, IMRIS emerged under a new LLC, brand, […]

Cerus Endovascular Provides Corporate Update

FREMONT, Calif. and OXFORD, England, Sept. 7, 2017 /PRNewswire/ — Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company engaged in the design and development of highly differentiated and proprietary interventional neuroradiology devices and delivery systems for the treatment of acute, life-threatening neurological conditions, specifically, intracranial aneurysm, today provided an update on its lead development […]

Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business

NICE, France, September 7, 2017 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today introduced CERENOVUS,** its new neurovascular business, at the European Society of Minimally Invasive Neurological Therapy (ESMINT) 9th Annual Meeting. CERENOVUS, a name derived from the Latin words for ‘new’ and ‘brain’, will focus on delivering innovative therapies for hemorrhagic […]

Cerebrotech Appoints Neurovascular Veteran Martin Dieck to Executive Chairman

PLEASANTON, Calif.–(BUSINESS WIRE)–Cerebrotech Medical Systems, an innovative medical device company focused on the development of a portable brain bioimpedance monitor, today announced that board member Martin Dieck, an experienced entrepreneur with expertise in developing novel neurovascular solutions, will step up to executive chairman, effectively immediately. “I am thrilled to have […]

InspireMD Shares CGuard EPS Video Testimonials From European Key Opinion Leaders

TEL AVIV, ISRAEL–(Marketwired – August 22, 2017) – InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (NYSE American: NSPR.WS) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has posted video testimonials about its CGuard™ Embolic Prevention System from […]

Canon Virginia, Inc. Collaborates with CVR Medical to Manufacture Intuitive, Next-Generation Stroke Prevention Technology

NEWS PROVIDED BY Canon U.S.A., Inc.  10:18 ET NEWPORT NEWS, Va., Aug. 7, 2017 /PRNewswire/ — After recently extending its full range of services to include medical device contract manufacturing and receiving  ISO 13485 certification, Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., announces an intent to collaborate with CVR Global […]

Pulsar and Neuravi Now Part of J&J’s New Cerenovous Neurovascular Business

Johnson & Johnson rolls Pulsar Vascular, Neuravi into new Cerenovus neurovascular biz JULY 25, 2017 BY BRAD PERRIELLO  – MassDevice Johnson & Johnson (NYSE:JNJ) said yesterday that it’s medical device division is rolling the Pulsar Vascular and Neuravi acquisitions into a new neurovascular business dubbed Cerenovus. The New Brunswick, N.J.-based healthcare giant said the new brand, unveiled at […]

Rapid Medical Snags $9 Million to Advance Commercialization of Stroke Products

YOKNEAM, Israel, July 17, 2017 /PRNewswire/ — Rapid Medical, a company focused on the development of neurovascular interventional devices, announced today that it has completed a Series B financing of $9M to advance the commercialization of the company’s minimally invasive stroke treatment and prevention products, the TIGERTRIEVER Revascularization Device, and the COMANECI, Adjustable Remodeling Mesh. […]